ID   CLSA_ECOLI              Reviewed;         486 AA.
AC   P0A6H8; P31071; P94720; P94730; P94733; P94740;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 1.
DT   15-MAR-2017, entry version 97.
DE   RecName: Full=Cardiolipin synthase A {ECO:0000255|HAMAP-Rule:MF_00190};
DE            Short=CL synthase {ECO:0000255|HAMAP-Rule:MF_00190};
DE            EC=2.7.8.- {ECO:0000255|HAMAP-Rule:MF_00190};
GN   Name=clsA {ECO:0000255|HAMAP-Rule:MF_00190}; Synonyms=cls, nov, yciJ;
GN   OrderedLocusNames=b1249, JW1241;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8170937; DOI=10.1073/pnas.91.9.3510;
RA   Milkman R.;
RT   "An Escherichia coli homologue of eukaryotic potassium channel
RT   proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3510-3514(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=7896699; DOI=10.1128/jb.177.7.1766-1771.1995;
RA   Ivanisevic R., Milic M., Ajdic D., Rakonjac J.V., Savic D.J.;
RT   "Nucleotide sequence, mutational analysis, transcriptional start site,
RT   and product analysis of nov, the gene which affects Escherichia coli
RT   K-12 resistance to the gyrase inhibitor novobiocin.";
RL   J. Bacteriol. 177:1766-1771(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / C600 / ATCC 23724 / DSM 3925 / LMG 3041 / NCIB 10222;
RA   Shibuya I., Asami Y., Uetake N., Ohta A., Matsuzaki H., Matsumoto K.;
RL   Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RA   Xia W., Dowhan W.;
RL   Submitted (OCT-1994) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12, and Various ECOR strains;
RA   Milkman R.;
RL   Submitted (APR-1995) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097039; DOI=10.1093/dnares/3.6.363;
RA   Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K., Itoh T.,
RA   Kasai H., Kashimoto K., Kimura S., Kitakawa M., Kitagawa M.,
RA   Makino K., Miki T., Mizobuchi K., Mori H., Mori T., Motomura K.,
RA   Nakade S., Nakamura Y., Nashimoto H., Nishio Y., Oshima T., Saito N.,
RA   Sampei G., Seki Y., Sivasundaram S., Tagami H., Takeda J.,
RA   Takemoto K., Takeuchi Y., Wada C., Yamamoto Y., Horiuchi T.;
RT   "A 570-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 28.0-40.1 min region on the linkage map.";
RL   DNA Res. 3:363-377(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [9]
RP   IDENTIFICATION OF CLS AS NOV, AND DISRUPTION PHENOTYPE.
RX   PubMed=7665497; DOI=10.1128/jb.177.17.5155-5157.1995;
RA   Tropp B.E., Ragolia L., Xia W., Dowhan W., Milkman R., Rudd K.E.,
RA   Ivanisevic R., Savic D.J.;
RT   "Identity of the Escherichia coli cls and nov genes.";
RL   J. Bacteriol. 177:5155-5157(1995).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBCELLULAR LOCATION.
RC   STRAIN=K12;
RX   PubMed=1663113;
RA   Hiraoka S., Nukui K., Uetake N., Ohta A., Shibuya I.;
RT   "Amplification and substantial purification of cardiolipin synthase of
RT   Escherichia coli.";
RL   J. Biochem. 110:443-449(1991).
RN   [11]
RP   REVIEW.
RX   PubMed=9370333; DOI=10.1016/S0005-2760(97)00100-8;
RA   Tropp B.E.;
RT   "Cardiolipin synthase from Escherichia coli.";
RL   Biochim. Biophys. Acta 1348:192-200(1997).
RN   [12]
RP   SUBCELLULAR LOCATION.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=15919996; DOI=10.1126/science.1109730;
RA   Daley D.O., Rapp M., Granseth E., Melen K., Drew D., von Heijne G.;
RT   "Global topology analysis of the Escherichia coli inner membrane
RT   proteome.";
RL   Science 308:1321-1323(2005).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, DISRUPTION PHENOTYPE, AND GENE NAME.
RX   PubMed=19341704; DOI=10.1016/j.bbamem.2009.03.016;
RA   Quigley B.R., Tropp B.E.;
RT   "E. coli cardiolipin synthase: function of N-terminal conserved
RT   residues.";
RL   Biochim. Biophys. Acta 1788:2107-2113(2009).
RN   [14]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF 2-THR--GLU-60; 7-LYS-VAL-8;
RP   30-LYS--ARG-32 AND GLY-59.
RX   PubMed=22988102; DOI=10.1073/pnas.1212797109;
RA   Tan B.K., Bogdanov M., Zhao J., Dowhan W., Raetz C.R., Guan Z.;
RT   "Discovery of a cardiolipin synthase utilizing
RT   phosphatidylethanolamine and phosphatidylglycerol as substrates.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:16504-16509(2012).
CC   -!- FUNCTION: Catalyzes the reversible phosphatidyl group transfer
CC       from one phosphatidylglycerol molecule to another to form
CC       cardiolipin (CL) (diphosphatidylglycerol) and glycerol.
CC       {ECO:0000255|HAMAP-Rule:MF_00190, ECO:0000269|PubMed:1663113,
CC       ECO:0000269|PubMed:19341704}.
CC   -!- CATALYTIC ACTIVITY: 2 Phosphatidylglycerol =
CC       diphosphatidylglycerol + glycerol. {ECO:0000255|HAMAP-
CC       Rule:MF_00190, ECO:0000269|PubMed:1663113,
CC       ECO:0000269|PubMed:19341704}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 7.0. {ECO:0000269|PubMed:1663113};
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_00190, ECO:0000269|PubMed:15919996,
CC       ECO:0000269|PubMed:1663113, ECO:0000269|PubMed:22988102}; Multi-
CC       pass membrane protein {ECO:0000255|HAMAP-Rule:MF_00190,
CC       ECO:0000269|PubMed:15919996, ECO:0000269|PubMed:1663113,
CC       ECO:0000269|PubMed:22988102}.
CC   -!- PTM: Seems to be post-translationally processed from a 53-55 kDa
CC       form to a 45-46 kDa form (PubMed:7665497 and PubMed:19341704).
CC   -!- DISRUPTION PHENOTYPE: Mutants have increased sensitivity to
CC       novobiocin. Triple deletion of clsA, clsB and clsC results in a
CC       complete lack of cardiolipin, regardless of growth phase or growth
CC       conditions. {ECO:0000269|PubMed:19341704,
CC       ECO:0000269|PubMed:7665497}.
CC   -!- MISCELLANEOUS: All three cardiolipin synthases (ClsA, ClsB and
CC       ClsC) contribute to CL synthesis in stationary phase. Only ClsA
CC       contributes to synthesis during logarithmic growth phase
CC       (PubMed:22988102). {ECO:0000305|PubMed:22988102}.
CC   -!- SIMILARITY: Belongs to the phospholipase D family. Cardiolipin
CC       synthase subfamily. ClsA sub-subfamily. {ECO:0000255|HAMAP-
CC       Rule:MF_00190}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L12044; AAA66948.1; -; Genomic_DNA.
DR   EMBL; U01911; AAA82872.1; -; Genomic_DNA.
DR   EMBL; D38779; BAA07636.1; -; Genomic_DNA.
DR   EMBL; U15986; AAA53368.1; -; Genomic_DNA.
DR   EMBL; U24206; AAB60160.1; -; Genomic_DNA.
DR   EMBL; U24195; AAB60072.1; -; Genomic_DNA.
DR   EMBL; U24196; AAB60080.1; -; Genomic_DNA.
DR   EMBL; U24197; AAB60088.1; -; Genomic_DNA.
DR   EMBL; U24198; AAB60096.1; -; Genomic_DNA.
DR   EMBL; U24199; AAB60104.1; -; Genomic_DNA.
DR   EMBL; U24200; AAB60112.1; -; Genomic_DNA.
DR   EMBL; U24201; AAB60120.1; -; Genomic_DNA.
DR   EMBL; U24202; AAB60128.1; -; Genomic_DNA.
DR   EMBL; U24203; AAB60136.1; -; Genomic_DNA.
DR   EMBL; U24204; AAB60144.1; -; Genomic_DNA.
DR   EMBL; U24205; AAB60152.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74331.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA14781.1; -; Genomic_DNA.
DR   PIR; A56145; A56145.
DR   RefSeq; NP_415765.1; NC_000913.3.
DR   RefSeq; WP_000214516.1; NZ_LN832404.1.
DR   ProteinModelPortal; P0A6H8; -.
DR   SMR; P0A6H8; -.
DR   BioGrid; 4260112; 279.
DR   STRING; 511145.b1249; -.
DR   PaxDb; P0A6H8; -.
DR   PRIDE; P0A6H8; -.
DR   EnsemblBacteria; AAC74331; AAC74331; b1249.
DR   EnsemblBacteria; BAA14781; BAA14781; BAA14781.
DR   GeneID; 945821; -.
DR   KEGG; ecj:JW1241; -.
DR   KEGG; eco:b1249; -.
DR   PATRIC; 32117758; VBIEscCol129921_1299.
DR   EchoBASE; EB1565; -.
DR   EcoGene; EG11608; clsA.
DR   eggNOG; ENOG4105CQX; Bacteria.
DR   eggNOG; COG1502; LUCA.
DR   HOGENOM; HOG000077403; -.
DR   InParanoid; P0A6H8; -.
DR   KO; K06131; -.
DR   OMA; FFKQDSG; -.
DR   PhylomeDB; P0A6H8; -.
DR   BioCyc; EcoCyc:CARDIOLIPSYN-MONOMER; -.
DR   BioCyc; MetaCyc:CARDIOLIPSYN-MONOMER; -.
DR   BRENDA; 2.7.8.B10; 2026.
DR   PRO; PR:P0A6H8; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:EcoCyc.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008808; F:cardiolipin synthase activity; IDA:EcoCyc.
DR   GO; GO:0032049; P:cardiolipin biosynthetic process; IMP:EcoCyc.
DR   HAMAP; MF_00190; Cardiolipin_synth_ClsA; 1.
DR   InterPro; IPR022924; Cardiolipin_synthase.
DR   InterPro; IPR030840; CL_synthase_A.
DR   InterPro; IPR027379; CLS_N.
DR   InterPro; IPR025202; PLD-like_dom.
DR   InterPro; IPR001736; PLipase_D/transphosphatidylase.
DR   Pfam; PF13091; PLDc_2; 2.
DR   Pfam; PF13396; PLDc_N; 1.
DR   SMART; SM00155; PLDc; 2.
DR   TIGRFAMs; TIGR04265; bac_cardiolipin; 1.
DR   PROSITE; PS50035; PLD; 2.
PE   1: Evidence at protein level;
KW   Cell inner membrane; Cell membrane; Complete proteome;
KW   Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Phospholipid biosynthesis; Phospholipid metabolism;
KW   Reference proteome; Repeat; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    486       Cardiolipin synthase A.
FT                                /FTId=PRO_0000201253.
FT   TRANSMEM      3     23       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_00190}.
FT   TRANSMEM     38     58       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_00190}.
FT   DOMAIN      219    246       PLD phosphodiesterase 1.
FT                                {ECO:0000255|HAMAP-Rule:MF_00190}.
FT   DOMAIN      399    426       PLD phosphodiesterase 2.
FT                                {ECO:0000255|HAMAP-Rule:MF_00190}.
FT   ACT_SITE    224    224       {ECO:0000255|HAMAP-Rule:MF_00190}.
FT   ACT_SITE    226    226       {ECO:0000255|HAMAP-Rule:MF_00190}.
FT   ACT_SITE    231    231       {ECO:0000255|HAMAP-Rule:MF_00190}.
FT   ACT_SITE    404    404       {ECO:0000255|HAMAP-Rule:MF_00190}.
FT   ACT_SITE    406    406       {ECO:0000255|HAMAP-Rule:MF_00190}.
FT   ACT_SITE    411    411       {ECO:0000255|HAMAP-Rule:MF_00190}.
FT   VARIANT     113    113       I -> S (in strain: ECOR 60).
FT   VARIANT     283    283       E -> G (in strain: ECOR 50).
FT   VARIANT     378    378       G -> S (in strain: ECOR 16).
FT   VARIANT     426    426       S -> R (in strain: ECOR 46).
FT   MUTAGEN       2     60       Missing: Remains membrane associated and
FT                                retains in vitro and in vivo activity.
FT                                {ECO:0000269|PubMed:22988102}.
FT   MUTAGEN       7      8       LV->SS: Retains in vitro activity, but
FT                                loses most of its in vivo activity.
FT                                Higher apparent molecular mass than wild-
FT                                type protein.
FT                                {ECO:0000269|PubMed:22988102}.
FT   MUTAGEN      30     32       KRR->TTT: Undergoes altered post-
FT                                translational processing and has much
FT                                lower in vivo and in vitro activity.
FT                                {ECO:0000269|PubMed:22988102}.
FT   MUTAGEN      59     59       G->A: Does not affect CL synthase
FT                                processing or activity.
FT                                {ECO:0000269|PubMed:22988102}.
SQ   SEQUENCE   486 AA;  54822 MW;  C8BDD69AA5AA37DB CRC64;
     MTTVYTLVSW LAILGYWLLI AGVTLRILMK RRAVPSAMAW LLIIYILPLV GIIAYLAVGE
     LHLGKRRAER ARAMWPSTAK WLNDLKACKH IFAEENSSVA APLFKLCERR QGIAGVKGNQ
     LQLMTESDDV MQALIRDIQL ARHNIEMVFY IWQPGGMADQ VAESLMAAAR RGIHCRLMLD
     SAGSVAFFRS PWPELMRNAG IEVVEALKVN LMRVFLRRMD LRQHRKMIMI DNYIAYTGSM
     NMVDPRYFKQ DAGVGQWIDL MARMEGPIAT AMGIIYSCDW EIETGKRILP PPPDVNIMPF
     EQASGHTIHT IASGPGFPED LIHQALLTAA YSAREYLIMT TPYFVPSDDL LHAICTAAQR
     GVDVSIILPR KNDSMLVGWA SRAFFTELLA AGVKIYQFEG GLLHTKSVLV DGELSLVGTV
     NLDMRSLWLN FEITLAIDDK GFGADLAAVQ DDYISRSRLL DARLWLKRPL WQRVAERLFY
     FFSPLL
//
